Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein

被引:124
作者
Akao, Y
Mizoguchi, H
Kojima, S
Naoe, T
Ohishi, N
Yagi, K
机构
[1] Gifu Int Inst Biotechnol, Mitake, Tokyo 5050116, Japan
[2] Nagoya First Red Cross Hosp, Dept Paediat, Nagoya, Aichi, Japan
[3] Nagoya Univ, Sch Med, Dept Infect Dis, Nagoya, Aichi 466, Japan
[4] Inst Appl Biochem, Yagi Mem Pk, Gifu, Japan
关键词
leukaemia; arsenic trioxide; apoptosis; caspases; Bcl-2;
D O I
10.1046/j.1365-2141.1998.00869.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We showed that arsenic inhibited the cell growth of four B-cell leukaemia cell lines of 11 various cell lines in vitro. In two of these four lines, KOCL44 and LyH7, apoptosis was identified by morphological and nucleosomal DNA fragmentation studies. Three of the four B-cell lines that were growth inhibited were acute infantile leukaemia with t(11:19)(q23;p13) translocations involving the MLL gene that encodes the transcriptional factor Drosophila trithorax. The arsenic-induced apoptosis in KOCL44 and LyH7 cells was found to be linked to caspases by Western blot and enzymological analyses. The amount of Bcl-2 was reduced during apoptosis in LyH7 as judged by Western blot analysis. We concluded that combined activation of the caspases and down-regulation of Bcl-2 could determine the fate of B-cell leukaemic cells in response to arsenic.
引用
收藏
页码:1055 / 1060
页数:6
相关论文
共 12 条
  • [1] AKAO Y, 1990, CANCER RES, V50, P4856
  • [2] Chen GQ, 1996, BLOOD, V88, P1052
  • [3] PHENOTYPIC AND GENOTYPIC CHARACTERIZATION OF 14 LEUKEMIA AND LYMPHOMA CELL-LINES WITH 11Q23 TRANSLOCATIONS
    IIDA, S
    SAITO, M
    OKAZAKI, T
    SETO, M
    YAMAMOTO, K
    AKAO, Y
    OGURA, M
    SUZUKI, H
    ARIYOSHI, Y
    KOIKE, K
    NITTA, M
    TAKAHASHI, T
    UEDA, R
    NAKAZAWA, S
    [J]. LEUKEMIA RESEARCH, 1992, 16 (12) : 1155 - 1163
  • [4] Markwell M A, 1981, Methods Enzymol, V72, P296
  • [5] INDUCTION OF APOPTOSIS IN FIBROBLASTS BY IL-1-BETA-CONVERTING ENZYME, A MAMMALIAN HOMOLOG OF THE C-ELEGANS CELL-DEATH GENE CED-3
    MIURA, M
    ZHU, H
    ROTELLO, R
    HARTWIEG, EA
    YUAN, JY
    [J]. CELL, 1993, 75 (04) : 653 - 660
  • [6] CYTOGENETIC CHARACTERIZATION OF A T-CELL LINE, ATN-1, DERIVED FROM ADULT T-CELL LEUKEMIA-CELLS
    NAOE, T
    AKAO, Y
    YAMADA, K
    UTSUMI, KR
    KOIKE, K
    SHAMOTO, M
    KOIE, K
    KUROSAWA, Y
    KATO, K
    ABE, M
    SHIKU, H
    [J]. CANCER GENETICS AND CYTOGENETICS, 1988, 34 (01) : 77 - 88
  • [7] LY1+ LYMPHOCYTE-PRO-B CLONES - PHENOTYPE, GROWTH REQUIREMENTS AND DIFFERENTIATION INVITRO AND INVIVO
    PALACIOS, R
    KARASUYAMA, H
    ROLINK, A
    [J]. EMBO JOURNAL, 1987, 6 (12) : 3687 - 3693
  • [8] Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APE) .2. Clinical efficacy and pharmacokinetics in relapsed patients
    Shen, ZX
    Chen, GQ
    Ni, JH
    Li, XS
    Xiong, SM
    Qiu, QY
    Zhu, J
    Tang, W
    Sun, GL
    Yang, KQ
    Chen, Y
    Zhou, L
    Fang, ZW
    Wang, YT
    Ma, J
    Zhang, P
    Zhang, TD
    Chen, SJ
    Chen, Z
    Wang, ZY
    [J]. BLOOD, 1997, 89 (09) : 3354 - 3360
  • [9] Shimizu S, 1996, ONCOGENE, V12, P2251
  • [10] BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
    Webb, A
    Cunningham, D
    Cotter, F
    Clarke, PA
    diStefano, F
    Ross, P
    Corbo, M
    Dziewanowska, Z
    [J]. LANCET, 1997, 349 (9059) : 1137 - 1141